State Action | Council For Citizens Against Government Waste

State Action

State Action

CCAGW Urges Ohio Representatives to Oppose House Bill 505

HB 505 would create unnecessary regulatory barriers that will undermine the effectiveness of pharmacy networks in Ohio.

Alec Mena May 14, 2024
State Action

CCAGW Urges Minnesota Legislators to Remove 340B Mandate from S.F. 4942

SF 4942's manufacturer mandate would change how the federal 340B drug pricing program operates in Minnesota.

Alec Mena May 8, 2024
State Action

CCAGW Urges Vermont Senators to Oppose H. 121

H. 121 will fail to achieve its objective of protecting consumer privacy

Alec Mena May 3, 2024
State Action

CCAGW Urges Kansas Senate Ways and Means Committee to Accept the 340B Amendment

The Kansas House Appropriations Committee’s amendment to Substitute for SB514 eliminates proposed changes to the federal 340B drug pricing program. 

Alec Mena April 26, 2024
State Action

CCAGW Urges Missouri Senators to Oppose Senate Bills 751, 843, 844, and 1105

S.B. 751, S.B. 843, S.B. 844, and S.B. 1105 which would each create unnecessary regulatory barriers that will undermine the effectiveness of pharmaceutical benefit managers (PBMs) in Missouri.

Alec Mena April 25, 2024
State Action

CCAGW Urges Missouri Representatives to Oppose House Bills 1627, 1628 and 2267

H.B. 1627, H.B. 1628, and H.B. 2267 would each create unnecessary regulatory barriers that will undermine the effectiveness of pharmaceutical benefit managers (PBMs) in Missouri.

Alec Mena April 25, 2024
State Action

CCAGW Urges Mississippi Legislators to Oppose House Bill 1265

HB 1265 would create unnecessary regulatory barriers to undermine the effectiveness of PBMs in Mississippi.

Alec Mena April 18, 2024
State Action

CCAGW Urges California Legislators to Oppose Senate Bill 966

SB 966 would create unnecessary regulatory barriers to undermine the effectiveness of pharmaceutical benefit managers (PBMs) in the Golden State.

Alec Mena April 16, 2024
State Action

CCAGW Urges Pennsylvania Legislators to Oppose Senate Bill 1000

SB 1000 creates unnecessary regulatory barriers that will undermine the effectiveness of PBMs in Pennsylvania.

Alec Mena April 9, 2024
State Action

CCAGW Urges Kansas Legislators to Oppose Amendment to SB 514

The move to amend Substitute for SB 514 will change how the federal 340B drug pricing program operates in the Sunflower State. 

Alec Mena April 5, 2024
State Action

CCAGW Urges Governor Reeves to Veto House Bill 728

HB 728 would change how the federal 340B program operates in Mississippi.  

Alec Mena April 4, 2024
State Action

CCAGW Urges Kentucky Representatives to Oppose SB 188

SB 188 would create unnecessary regulatory barriers that will undermine the effectiveness of pharmaceutical benefit managers (PBMs) in Kentucky.

Alec Mena March 28, 2024

Pages